Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier.

van Doorn R, Lopes Pinheiro MA, Kooij G, Lakeman K, van het Hof B, van der Pol SM, Geerts D, van Horssen J, van der Valk P, van der Kam E, Ronken E, Reijerkerk A, de Vries HE.

J Neuroinflammation. 2012 Jun 20;9:133. doi: 10.1186/1742-2094-9-133.

2.

Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions.

Van Doorn R, Van Horssen J, Verzijl D, Witte M, Ronken E, Van Het Hof B, Lakeman K, Dijkstra CD, Van Der Valk P, Reijerkerk A, Alewijnse AE, Peters SL, De Vries HE.

Glia. 2010 Sep;58(12):1465-76. doi: 10.1002/glia.21021.

PMID:
20648639
3.

Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats.

Homberg JR, De Boer SF, Raasø HS, Olivier JD, Verheul M, Ronken E, Cools AR, Ellenbroek BA, Schoffelmeer AN, Vanderschuren LJ, De Vries TJ, Cuppen E.

Psychopharmacology (Berl). 2008 Oct;200(3):367-80. doi: 10.1007/s00213-008-1212-x. Epub 2008 Jun 27.

PMID:
18581099
4.

Protective effects of peroxiredoxin-1 at the injured blood-brain barrier.

Schreibelt G, van Horssen J, Haseloff RF, Reijerkerk A, van der Pol SM, Nieuwenhuizen O, Krause E, Blasig IE, Dijkstra CD, Ronken E, de Vries HE.

Free Radic Biol Med. 2008 Aug 1;45(3):256-64. doi: 10.1016/j.freeradbiomed.2008.03.024. Epub 2008 Apr 16.

PMID:
18452719
5.

Serotonin transporter deficiency in rats improves inhibitory control but not behavioural flexibility.

Homberg JR, Pattij T, Janssen MC, Ronken E, De Boer SF, Schoffelmeer AN, Cuppen E.

Eur J Neurosci. 2007 Oct;26(7):2066-73.

PMID:
17897403
6.

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling.

Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, de Vries HE.

FASEB J. 2007 Nov;21(13):3666-76. Epub 2007 Jun 22.

PMID:
17586731
7.

Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system.

Homberg JR, Olivier JD, Smits BM, Mul JD, Mudde J, Verheul M, Nieuwenhuizen OF, Cools AR, Ronken E, Cremers T, Schoffelmeer AN, Ellenbroek BA, Cuppen E.

Neuroscience. 2007 Jun 8;146(4):1662-76. Epub 2007 Apr 30.

PMID:
17467186
8.

In situ entry of oligonucleotides into brain cells can occur through a nucleic acid channel.

Shi F, Gounko NV, Wang X, Ronken E, Hoekstra D.

Oligonucleotides. 2007 Spring;17(1):122-33.

PMID:
17461769
9.

Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats.

Bouwmeester H, Gerrits MA, Roozemond JG, Snapper J, Ronken E, Kruse CG, Westenberg HG, van Ree JM.

Int J Neuropsychopharmacol. 2007 Dec;10(6):727-39. Epub 2006 Nov 1.

PMID:
17076936
10.

In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.

Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.

Synapse. 2006 Dec 15;60(8):599-608.

PMID:
17001660
11.

Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival.

Vallès A, Grijpink-Ongering L, de Bree FM, Tuinstra T, Ronken E.

Neurobiol Dis. 2006 May;22(2):312-22. Epub 2006 Feb 2.

PMID:
16472549
12.

Structure-activity studies on the corticotropin releasing factor antagonist astressin, leading to a minimal sequence necessary for antagonistic activity.

Rijkers DT, Kruijtzer JA, van Oostenbrugge M, Ronken E, den Hartog JA, Liskamp RM.

Chembiochem. 2004 Mar 5;5(3):340-8.

PMID:
14997526
13.

Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.

Lange JH, Coolen HK, van Stuivenberg HH, Dijksman JA, Herremans AH, Ronken E, Keizer HG, Tipker K, McCreary AC, Veerman W, Wals HC, Stork B, Verveer PC, den Hartog AP, de Jong NM, Adolfs TJ, Hoogendoorn J, Kruse CG.

J Med Chem. 2004 Jan 29;47(3):627-43.

PMID:
14736243
14.

Antisense oligonucleotides reach mRNA targets via the RNA matrix: downregulation of the 5-HT1A receptor.

Shi F, Visser WH, de Jong NM, Liem RS, Ronken E, Hoekstra D.

Exp Cell Res. 2003 Dec 10;291(2):313-25.

PMID:
14644154
15.

Effects of neonatal amygdala lesions on [125I] neurotensin binding in specific brain areas of adult rat.

Bouwmeester H, Snapper J, Ronken E, Kruse CG, van Ree JM.

Eur J Neurosci. 2003 Mar;17(6):1319-22.

PMID:
12670322
16.

Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations.

Dirks A, Groenink L, Bouwknecht JA, Hijzen TH, Van Der Gugten J, Ronken E, Verbeek JS, Veening JG, Dederen PJ, Korosi A, Schoolderman LF, Roubos EW, Olivier B.

Eur J Neurosci. 2002 Nov;16(9):1751-60.

PMID:
12431228
17.

Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists.

Stoit AR, Lange JH, Hartog AP, Ronken E, Tipker K, Stuivenberg HH, Dijksman JA, Wals HC, Kruse CG.

Chem Pharm Bull (Tokyo). 2002 Aug;50(8):1109-13.

18.

Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro.

Van der Goes A, Wouters D, Van Der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD, De Vries HE.

FASEB J. 2001 Aug;15(10):1852-4. No abstract available.

PMID:
11481252
19.
20.

Ultrasonic vocalizations in rat pups: effects of serotonergic ligands.

Olivier B, Molewijk HE, van der Heyden JA, van Oorschot R, Ronken E, Mos J, Miczek KA.

Neurosci Biobehav Rev. 1998;23(2):215-27.

PMID:
9884114
21.
22.

Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands.

Olivier B, Molewijk E, van Oorschot R, van der Heyden J, Ronken E, Mos J.

Eur J Pharmacol. 1998 Oct 2;358(2):117-28.

PMID:
9808260
23.

Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration.

Veening JG, Coolen LM, Spooren WJ, Joosten H, van Oorschot R, Mos J, Ronken E, Olivier B.

Eur Neuropsychopharmacol. 1998 Aug;8(3):213-26.

PMID:
9716316
24.

Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.

Smeets RL, Fouraux MA, Pouwels W, van Emst-de Vries SE, Ronken E, De Pont JJ, Willems PH.

Br J Pharmacol. 1998 Jul;124(5):935-45.

25.

Anxiolytic effects of flesinoxan in the stress-induced hyperthermia paradigm in singly-housed mice are 5-HT1A receptor mediated.

Olivier B, Zethof TJ, Ronken E, van der Heyden JA.

Eur J Pharmacol. 1998 Jan 26;342(2-3):177-82.

PMID:
9548383
26.

Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages.

De Vries HE, Ronken E, Reinders JH, Buchner B, Van Berkel TJ, Kuiper J.

FASEB J. 1998 Jan;12(1):111-8.

PMID:
9438416
27.

In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands.

Rijks LJ, Booij J, Doornbos T, Boer GJ, Ronken E, de Bruin K, Vermeulen RJ, Janssen AG, Van Royen EA.

Synapse. 1996 Jul;23(3):201-7.

PMID:
8807748
28.
29.
30.
32.

Interacting presynaptic kappa-opioid and GABAA receptors modulate dopamine release from rat striatal synaptosomes.

Ronken E, Mulder AH, Schoffelmeer AN.

J Neurochem. 1993 Nov;61(5):1634-9.

PMID:
8228982
33.

Topography and characteristics of specific binding sites for non-opioid gamma-type endorphins in the rat brain as studied by autoradiography with [35S]Met-desenkephalin-gamma-endorphin.

Ronken E, Wiegant VM, Kaspersen FM, van Nispen JW, de Boer T, Bruning HW, Rust CJ, Tonnaer JA.

Brain Res. 1993 Jun 25;615(1):63-70.

PMID:
8395956
34.

Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus.

Ronken E, Van Muiswinkel FL, Mulder AH, Schoffelmeer AN.

Eur J Pharmacol. 1993 Jan 19;230(3):349-55.

PMID:
8095023
35.

Endorphins and schizophrenia.

Wiegant VM, Ronken E, Kovács G, De Wied D.

Prog Brain Res. 1992;93:433-53. Review. No abstract available.

PMID:
1480761
36.

Binding sites for non-opioid gamma-type endorphins in brain structures of the mesocorticolimbic feedback circuit.

Wiegant VM, Ronken E, de Boer T, Tonnaer JA.

Prog Clin Biol Res. 1990;328:29-32. No abstract available.

PMID:
1689494
37.

Autoradiographic evidence for binding sites for des-enkephalin-gamma-endorphin (ORG 5878) in rat forebrain.

Ronken E, Tonnaer JA, De Boer T, Wiegant VM.

Eur J Pharmacol. 1989 Mar 14;162(1):189-91. No abstract available.

PMID:
2524395

Supplemental Content

Loading ...
Support Center